Bonnie Donato
Executive Director, Health Economics & Outcomes Research, Cardio-Renal-Metabolic Boehringer Ingelheim
Bonnie M.K. Donato, PhD, is a health economist with more than 25 years of experience in the pharmaceutical and biopharmaceutical industry. Her expertise in health economics and outcomes research (HEOR) spans global, regional, and U.S. roles, where she has led teams responsible for developing and executing value evidence strategies and evidence generation programs. Her work focuses on demonstrating the economic and humanistic value of healthcare interventions for patients, providers, and the broader healthcare system, supporting informed decision-making and patient access.
Dr. Donato joined Boehringer Ingelheim in 2018 as Executive Director, HEOR Value Demonstration for Cardio-Renal-Metabolic diseases. She is widely recognized for her leadership in the HEOR field and has an extensive record of publications and presentations advancing health economic and outcomes research.
Seminars
- Re-articulating the strategic value of HEOR beyond ‘supporting’ clinical evidence
- Demonstrating ROI when studies take 12–24 months but decisions demand speed
- Building stronger advocacy and communication skills within HEOR leadership
